Here's why you should be paying attention to this new, upcoming Alzheimer disease treatment...

Learn how clinicians can better recognize, diagnose, and support patients struggling with addiction through proactive screening and honest conversations.

COVID-19 increased the usage of telemedicine drastically, but is that always a good thing?

Check out these top 10 best practices for treating patients with mood disorders.

Facing limited resources, cultural barriers, and complex mental health cases, A newly qualified doctor’s year in rural South Africa offers a deep dive into psychiatry in underserved areas.

A new report addressing misinformation in science lays out how we can best distinguish truth from fiction.

Comparing the inaugural oath and the Hippocratic oath…

The FDA has approved the supplemental New Drug Application for Spravato, the first and only monotherapy for adults with treatment-resistant depression.

What 5 factors should you look at when selecting ADHD treatment?

Check out the top 5 best practice recommendations for treating children and adolescents with psychotropic and combination therapies.

How can a whole-patient approach improve treatment for alcohol use disorder (AUD)? Joseph Volpicelli, MD, PhD, shares expert insights on evidence-based strategies, patient collaboration, and the role of medications like naltrexone in long-term recovery.

Let's explore COVID-19's impact on psychiatric research...

Let's define success for patients with ADHD...

"Who are you important to? If you passed tomorrow, who would show up at your funeral?"

When a patient has comorbidities like anxiety, substance use, and depression, how can you best select a treatment?

Come celebrate the evolution of Psychiatric Times and psychiatry as a whole!

When prescribing ADHD medications, when is the best time to switch treatments?

Panelists discuss early signs of a positive response to treatment in postpartum depression (PPD), the specific symptoms to monitor, obstacles to accessing timely care in underserved populations, the role of family and community resources in recovery, key competencies for clinicians in addressing urgent PPD cases, and essential elements of a comprehensive, patient-centered treatment plan that balances medication, therapy, and support resources.

Panelists discuss the strategic decision-making process for choosing among selective serotonin reuptake inhibitors (SSRIs), rapid-onset treatments like zuranolone, and nonmedication therapies for postpartum depression (PPD), emphasizing the importance of treatment speed, severity of symptoms, and patient preferences.

Does the psychiatric approach to treating women need to change? How does feminist thought consider psychiatric treatment? Linda Gask, Msc, PhD, shares her thoughts in "Out of Her Mind".

How can we improve patient outcomes? Collaboration.

Ancillary symptoms may be key in guiding treatment management for ADHD.

Here are 4 things to do when implementing a treatment strategy for tardive dyskinesia.

Comorbid bipolar disorder and ADHD: a big problem.

Here's how to have productive conversations with patients with tardive dyskinesia in order to improve outcomes.